The company has disclosed details regarding its completed share repurchase program.

As of May 31, 2026, Cofoe Medical (ASX: 01187) had repurchased a total of 3.32 million of its own A-shares through a dedicated securities account using centralized competitive bidding.

These repurchased shares represent approximately 1.59% of the company's total outstanding A-share capital.

The transaction was executed at prices ranging from a high of 58.944 yuan per share to a low of 51.57 yuan per share.

The total consideration for the buyback amounted to 181 million yuan, excluding associated transaction costs.

The company has confirmed that this share repurchase was conducted in full compliance with its approved buyback plan and all relevant laws and regulations.